Experience
Representing plaintiff Novartis in a Hatch-Waxman litigation regarding generic version of Novartis’s Gilenya® product for multiple sclerosis indication.
Representing plaintiff Healthgen in a patent infringement action regarding patents related to extraction and purification of recombinant human serum albumin.
Have represented innovators and challengers in proceedings relating to multiple unique biologic products.
Obtained a complete win for Seagen of willful infringement, no invalidity, and all requested damages in a jury trial involving antibody-drug conjugate technology.
Obtained favorable outcome for plaintiff in a trade secret and breach of contract dispute involving gene therapy for neurodegenerative diseases.